"Approval Date","Drug Name","Submission","Active Ingredients","Company","Submission Classification *","Submission Status"
"04/02/2017","PRIMAXINANDA  #062756","SUPPL-56","CILASTATIN SODIUM; IMIPENEM","MERCK","Labeling","Approval"
"04/03/2017","DEPO-PROVERANDA   #012541","SUPPL-86","MEDROXYPROGESTERONE ACETATE","PFIZER","Labeling","Approval"
"04/03/2017","CHILDREN'S MOTRIN COLDNDA   #021128","SUPPL-10","IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE","J AND J CONSUMER INC","Labeling","Approval"
"04/03/2017","MONODOXNDA   #050641","SUPPL-29","DOXYCYCLINE","CHARTWELL RX","Labeling","Approval"
"04/03/2017","CANDESARTAN CILEXETILANDA  #078702","SUPPL-3","CANDESARTAN CILEXETIL","MYLAN","Manufacturing (CMC)","Approval"
"04/03/2017","TRINTELLIXNDA   #204447","SUPPL-8","VORTIOXETINE HYDROBROMIDE","TAKEDA PHARMS USA","Labeling","Approval"
"04/03/2017","MOMETASONE FUROATEANDA  #207989","ORIG-1","MOMETASONE FUROATE","AMNEAL PHARMS","","Approval"
"04/03/2017","AUSTEDONDA   #208082","ORIG-1","DEUTETRABENAZINE","TEVA BRANDED PHARM","Type 1 - New Molecular Entity","Approval"
"04/03/2017","TAZAROTENEANDA  #208258","ORIG-1","TAZAROTENE","TARO PHARMS","","Approval"
"04/04/2017","GLIPIZIDE AND METFORMIN HYDROCHLORIDEANDA  #078728","SUPPL-2","GLIPIZIDE; METFORMIN HYDROCHLORIDE","HERITAGE PHARMS INC","Labeling","Approval"
"04/04/2017","BOTOXBLA   #103000","SUPPL-5296","OnabotulinumtoxinA","ALLERGAN","","Approval"
"04/04/2017","BOTOXBLA   #103000","SUPPL-5297","OnabotulinumtoxinA","ALLERGAN","","Approval"
"04/04/2017","BOTOXBLA   #103000","SUPPL-5298","OnabotulinumtoxinA","ALLERGAN","","Approval"
"04/04/2017","BOTOX COSMETICBLA   #103000","SUPPL-5296","OnabotulinumtoxinA","ALLERGAN","","Approval"
"04/04/2017","BOTOX COSMETICBLA   #103000","SUPPL-5297","OnabotulinumtoxinA","ALLERGAN","","Approval"
"04/04/2017","BOTOX COSMETICBLA   #103000","SUPPL-5298","OnabotulinumtoxinA","ALLERGAN","","Approval"
"04/04/2017","LORAZEPAMANDA  #200217","ORIG-1","LORAZEPAM","MYLAN ASI","","Approval"
"04/04/2017","GRANISETRON HYDROCHLORIDEANDA  #203454","ORIG-1","GRANISETRON HYDROCHLORIDE","MYLAN LABS LTD","","Approval"
"04/04/2017","CELECOXIBANDA  #207061","ORIG-1","CELECOXIB","JUBILANT GENERICS","","Approval"
"04/05/2017","CHOLOGRAFIN MEGLUMINENDA   #009321","SUPPL-30","IODIPAMIDE MEGLUMINE","BRACCO","Labeling","Approval"
"04/05/2017","CHOLOGRAFIN SODIUMNDA   #009321","SUPPL-30","IODIPAMIDE SODIUM","BRACCO","Labeling","Approval"
"04/05/2017","CONRAYNDA   #013295","SUPPL-70","IOTHALAMATE MEGLUMINE","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/05/2017","CONRAY 43NDA   #013295","SUPPL-70","IOTHALAMATE MEGLUMINE","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/05/2017","CONRAY 30NDA   #016983","SUPPL-37","IOTHALAMATE MEGLUMINE","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/05/2017","ISOVUE-128NDA   #018735","SUPPL-57","IOPAMIDOL","BRACCO","Labeling","Approval"
"04/05/2017","ISOVUE-200NDA   #018735","SUPPL-57","IOPAMIDOL","BRACCO","Labeling","Approval"
"04/05/2017","ISOVUE-250NDA   #018735","SUPPL-57","IOPAMIDOL","BRACCO","Labeling","Approval"
"04/05/2017","ISOVUE-300NDA   #018735","SUPPL-57","IOPAMIDOL","BRACCO","Labeling","Approval"
"04/05/2017","ISOVUE-370NDA   #018735","SUPPL-57","IOPAMIDOL","BRACCO","Labeling","Approval"
"04/05/2017","ISOVUE-M 200NDA   #018735","SUPPL-57","IOPAMIDOL","BRACCO","Labeling","Approval"
"04/05/2017","ISOVUE-M 300NDA   #018735","SUPPL-57","IOPAMIDOL","BRACCO","Labeling","Approval"
"04/05/2017","HEXABRIXNDA   #018905","SUPPL-25","IOXAGLATE MEGLUMINE; IOXAGLATE SODIUM","GUERBET","Labeling","Approval"
"04/05/2017","OMNIPAQUE 12NDA   #018956","SUPPL-99","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"04/05/2017","OMNIPAQUE 140NDA   #018956","SUPPL-99","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"04/05/2017","OMNIPAQUE 180NDA   #018956","SUPPL-99","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"04/05/2017","OMNIPAQUE 210NDA   #018956","SUPPL-99","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"04/05/2017","OMNIPAQUE 240NDA   #018956","SUPPL-99","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"04/05/2017","OMNIPAQUE 300NDA   #018956","SUPPL-99","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"04/05/2017","OMNIPAQUE 350NDA   #018956","SUPPL-99","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"04/05/2017","OMNIPAQUE 70NDA   #018956","SUPPL-99","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"04/05/2017","OMNIPAQUE 9NDA   #018956","SUPPL-99","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"04/05/2017","MD-76RNDA   #019292","SUPPL-11","DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/05/2017","OPTIRAY 160NDA   #019710","SUPPL-55","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/05/2017","OPTIRAY 240NDA   #019710","SUPPL-55","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/05/2017","OPTIRAY 300NDA   #019710","SUPPL-55","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/05/2017","OPTIRAY 320NDA   #019710","SUPPL-55","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/05/2017","OPTIRAY 350NDA   #019710","SUPPL-55","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/05/2017","ULTRAVIST 150NDA   #020220","SUPPL-42","IOPROMIDE","BAYER HLTHCARE","Labeling","Approval"
"04/05/2017","ULTRAVIST 240NDA   #020220","SUPPL-42","IOPROMIDE","BAYER HLTHCARE","Labeling","Approval"
"04/05/2017","ULTRAVIST 300NDA   #020220","SUPPL-42","IOPROMIDE","BAYER HLTHCARE","Labeling","Approval"
"04/05/2017","ULTRAVIST 300 IN PLASTIC CONTAINERNDA   #020220","SUPPL-42","IOPROMIDE","BAYER HLTHCARE","Labeling","Approval"
"04/05/2017","ULTRAVIST 370NDA   #020220","SUPPL-42","IOPROMIDE","BAYER HLTHCARE","Labeling","Approval"
"04/05/2017","OXILAN-300NDA   #020316","SUPPL-29","IOXILAN","GUERBET","Labeling","Approval"
"04/05/2017","OXILAN-350NDA   #020316","SUPPL-29","IOXILAN","GUERBET","Labeling","Approval"
"04/05/2017","ISOVUE-200NDA   #020327","SUPPL-12","IOPAMIDOL","BRACCO","Labeling","Approval"
"04/05/2017","ISOVUE-250NDA   #020327","SUPPL-12","IOPAMIDOL","BRACCO","Labeling","Approval"
"04/05/2017","ISOVUE-300NDA   #020327","SUPPL-12","IOPAMIDOL","BRACCO","Labeling","Approval"
"04/05/2017","ISOVUE-370NDA   #020327","SUPPL-12","IOPAMIDOL","BRACCO","Labeling","Approval"
"04/05/2017","VISIPAQUE 270NDA   #020351","SUPPL-44","IODIXANOL","GE HEALTHCARE","Efficacy","Approval"
"04/05/2017","VISIPAQUE 270NDA   #020351","SUPPL-45","IODIXANOL","GE HEALTHCARE","Labeling","Approval"
"04/05/2017","VISIPAQUE 320NDA   #020351","SUPPL-44","IODIXANOL","GE HEALTHCARE","Efficacy","Approval"
"04/05/2017","VISIPAQUE 320NDA   #020351","SUPPL-45","IODIXANOL","GE HEALTHCARE","Labeling","Approval"
"04/05/2017","GLUCOPHAGENDA   #020357","SUPPL-37","METFORMIN HYDROCHLORIDE","EMD SERONO INC","Labeling","Approval"
"04/05/2017","GLUCOPHAGENDA   #020357","SUPPL-39","METFORMIN HYDROCHLORIDE","EMD SERONO INC","Labeling","Approval"
"04/05/2017","OMNIPAQUE 240NDA   #020608","SUPPL-36","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"04/05/2017","OMNIPAQUE 240NDA   #020608","SUPPL-37","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"04/05/2017","OMNIPAQUE 300NDA   #020608","SUPPL-36","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"04/05/2017","OMNIPAQUE 300NDA   #020608","SUPPL-37","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"04/05/2017","OMNIPAQUE 350NDA   #020608","SUPPL-36","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"04/05/2017","OMNIPAQUE 350NDA   #020608","SUPPL-37","IOHEXOL","GE HEALTHCARE","Labeling","Approval"
"04/05/2017","VISIPAQUE 270NDA   #020808","SUPPL-25","IODIXANOL","GE HEALTHCARE","Efficacy","Approval"
"04/05/2017","VISIPAQUE 270NDA   #020808","SUPPL-26","IODIXANOL","GE HEALTHCARE","Labeling","Approval"
"04/05/2017","VISIPAQUE 320NDA   #020808","SUPPL-25","IODIXANOL","GE HEALTHCARE","Efficacy","Approval"
"04/05/2017","VISIPAQUE 320NDA   #020808","SUPPL-26","IODIXANOL","GE HEALTHCARE","Labeling","Approval"
"04/05/2017","OPTIRAY 240NDA   #020923","SUPPL-20","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/05/2017","OPTIRAY 300NDA   #020923","SUPPL-20","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/05/2017","OPTIRAY 320NDA   #020923","SUPPL-20","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/05/2017","OPTIRAY 350NDA   #020923","SUPPL-20","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/05/2017","GLUCOVANCENDA   #021178","SUPPL-16","GLYBURIDE; METFORMIN HYDROCHLORIDE","BRISTOL MYERS SQUIBB","Labeling","Approval"
"04/05/2017","GLUCOVANCENDA   #021178","SUPPL-17","GLYBURIDE; METFORMIN HYDROCHLORIDE","BRISTOL MYERS SQUIBB","Labeling","Approval"
"04/05/2017","GLUCOPHAGE XRNDA   #021202","SUPPL-21","METFORMIN HYDROCHLORIDE","EMD SERONO INC","Labeling","Approval"
"04/05/2017","GLUCOPHAGE XRNDA   #021202","SUPPL-23","METFORMIN HYDROCHLORIDE","EMD SERONO INC","Labeling","Approval"
"04/05/2017","AVANDAMETNDA   #021410","SUPPL-40","METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE","SB PHARMCO","Labeling","Approval"
"04/05/2017","ULTRAVIST (PHARMACY BULK)NDA   #021425","SUPPL-26","IOPROMIDE","BAYER HLTHCARE","Labeling","Approval"
"04/05/2017","FORTAMETNDA   #021574","SUPPL-20","METFORMIN HYDROCHLORIDE","ANDRX LABS LLC","Labeling","Approval"
"04/05/2017","RIOMETNDA   #021591","SUPPL-10","METFORMIN HYDROCHLORIDE","RANBAXY","Labeling","Approval"
"04/05/2017","GLUMETZANDA   #021748","SUPPL-20","METFORMIN HYDROCHLORIDE","SANTARUS INC","Labeling","Approval"
"04/05/2017","FLONASE SENSIMIST ALLERGY RELIEFNDA   #022051","SUPPL-14","FLUTICASONE FUROATE","GLAXOSMITHKLINE CONS","Labeling","Approval"
"04/05/2017","PRANDIMETNDA   #022386","SUPPL-18","METFORMIN HYDROCHLORIDE; REPAGLINIDE","NOVO NORDISK INC","Labeling","Approval"
"04/05/2017","GLIPIZIDE AND METFORMIN HYDROCHLORIDEANDA  #077270","SUPPL-11","GLIPIZIDE; METFORMIN HYDROCHLORIDE","TEVA PHARMS","Labeling","Approval"
"04/05/2017","ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDEANDA  #077337","SUPPL-1","METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE","TEVA","Labeling","Approval"
"04/05/2017","GLIPIZIDE AND METFORMIN HYDROCHLORIDEANDA  #077507","SUPPL-4","GLIPIZIDE; METFORMIN HYDROCHLORIDE","EPIC PHARMA LLC","Labeling","Approval"
"04/05/2017","GLIPIZIDE AND METFORMIN HYDROCHLORIDEANDA  #077620","SUPPL-13","GLIPIZIDE; METFORMIN HYDROCHLORIDE","SUN PHARM INDS INC","Labeling","Approval"
"04/05/2017","GLIPIZIDE AND METFORMIN HYDROCHLORIDEANDA  #078083","SUPPL-6","GLIPIZIDE; METFORMIN HYDROCHLORIDE","MYLAN","Labeling","Approval"
"04/05/2017","GLIPIZIDE AND METFORMIN HYDROCHLORIDEANDA  #078728","SUPPL-5","GLIPIZIDE; METFORMIN HYDROCHLORIDE","HERITAGE PHARMS INC","Labeling","Approval"
"04/05/2017","GLIPIZIDE AND METFORMIN HYDROCHLORIDEANDA  #078905","SUPPL-3","GLIPIZIDE; METFORMIN HYDROCHLORIDE","ZYDUS PHARMS USA INC","Labeling","Approval"
"04/05/2017","TROKENDI XRNDA   #201635","SUPPL-11","TOPIRAMATE","SUPERNUS PHARMS","Efficacy","Approval"
"04/05/2017","TROKENDI XRNDA   #201635","SUPPL-17","TOPIRAMATE","SUPERNUS PHARMS","Efficacy","Approval"
"04/05/2017","HYDROCODONE BITARTRATEANDA  #206952","ORIG-1","HYDROCODONE BITARTRATE","ACTAVIS LABS FL INC","","Tentative Approval"
"04/05/2017","FLUOXETINE HYDROCHLORIDEANDA  #208698","ORIG-1","FLUOXETINE HYDROCHLORIDE","ALEMBIC PHARMS LTD","","Approval"
"04/06/2017","TIMOPTIC IN OCUDOSENDA   #019463","SUPPL-31","TIMOLOL MALEATE","VALEANT PHARMS INTL","Labeling","Approval"
"04/06/2017","IOPIDINENDA   #019779","SUPPL-23","APRACLONIDINE HYDROCHLORIDE","NOVARTIS","Labeling","Approval"
"04/06/2017","IOPIDINENDA   #020258","SUPPL-26","APRACLONIDINE HYDROCHLORIDE","NOVARTIS","Labeling","Approval"
"04/06/2017","TYKERBNDA   #022059","SUPPL-22","LAPATINIB DITOSYLATE","NOVARTIS","Labeling","Approval"
"04/06/2017","BUPROPION HYDROCHLORIDEANDA  #090693","ORIG-1","BUPROPION HYDROCHLORIDE","LUPIN LTD","","Approval"
"04/06/2017","DULOXETINE HYDROCHLORIDEANDA  #090739","SUPPL-5","DULOXETINE HYDROCHLORIDE","ZYDUS HLTHCARE","Labeling","Approval"
"04/06/2017","DULOXETINE HYDROCHLORIDEANDA  #090739","SUPPL-6","DULOXETINE HYDROCHLORIDE","ZYDUS HLTHCARE","Labeling","Approval"
"04/06/2017","DULOXETINE HYDROCHLORIDEANDA  #090739","SUPPL-7","DULOXETINE HYDROCHLORIDE","ZYDUS HLTHCARE","Labeling","Approval"
"04/06/2017","DULOXETINE HYDROCHLORIDEANDA  #090739","SUPPL-10","DULOXETINE HYDROCHLORIDE","ZYDUS HLTHCARE","Labeling","Approval"
"04/06/2017","DULOXETINE HYDROCHLORIDEANDA  #090739","SUPPL-11","DULOXETINE HYDROCHLORIDE","ZYDUS HLTHCARE","Manufacturing (CMC)","Approval"
"04/06/2017","DULOXETINE HYDROCHLORIDEANDA  #090739","SUPPL-12","DULOXETINE HYDROCHLORIDE","ZYDUS HLTHCARE","Labeling","Approval"
"04/06/2017","ABACAVIR AND LAMIVUDINENDA   #208775","ORIG-1","ABACAVIR; LAMIVUDINE","CIPLA LIMITED","Type 3 - New Dosage Form","Tentative Approval"
"04/07/2017","CORDARONENDA   #018972","SUPPL-53","AMIODARONE HYDROCHLORIDE","WYETH PHARMS","Labeling","Approval"
"04/07/2017","VIREADNDA   #021356","SUPPL-55","TENOFOVIR DISOPROXIL FUMARATE","GILEAD SCIENCES INC","Labeling","Approval"
"04/07/2017","EMTRIVANDA   #021500","SUPPL-28","EMTRICITABINE","GILEAD","Labeling","Approval"
"04/07/2017","EMTRIVANDA   #021896","SUPPL-25","EMTRICITABINE","GILEAD","Labeling","Approval"
"04/07/2017","ATRIPLANDA   #021937","SUPPL-41","EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD SCIENCES","Labeling","Approval"
"04/07/2017","VIREADNDA   #022577","SUPPL-11","TENOFOVIR DISOPROXIL FUMARATE","GILEAD SCIENCES INC","Labeling","Approval"
"04/07/2017","HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040148","SUPPL-51","ACETAMINOPHEN; HYDROCODONE BITARTRATE","APIL","Manufacturing (CMC)","Approval"
"04/07/2017","NORCOANDA  #040148","SUPPL-51","ACETAMINOPHEN; HYDROCODONE BITARTRATE","APIL","Manufacturing (CMC)","Approval"
"04/07/2017","LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #090229","SUPPL-16","LEVOCETIRIZINE DIHYDROCHLORIDE","SYNTHON PHARMS","Manufacturing (CMC)","Approval"
"04/07/2017","COMPLERANDA   #202123","SUPPL-27","EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD SCIENCES INC","Labeling","Approval"
"04/07/2017","STRIBILDNDA   #203100","SUPPL-28","COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD SCIENCES INC","Labeling","Approval"
"04/07/2017","DUTASTERIDEANDA  #204376","ORIG-1","DUTASTERIDE","MARKSANS PHARMA","","Approval"
"04/07/2017","SOVALDINDA   #204671","SUPPL-6","SOFOSBUVIR","GILEAD SCIENCES INC","Efficacy","Approval"
"04/07/2017","FENOFIBRATE (MICRONIZED)ANDA  #205566","ORIG-1","FENOFIBRATE","GLENMARK PHARMS LTD","","Approval"
"04/07/2017","HARVONINDA   #205834","SUPPL-17","LEDIPASVIR; SOFOSBUVIR","GILEAD SCIENCES INC","Efficacy","Approval"
"04/07/2017","ATRACURIUM BESYLATE PRESERVATIVE FREEANDA  #206001","ORIG-1","ATRACURIUM BESYLATE","MYLAN LABS LTD","","Approval"
"04/07/2017","SIMPESSEANDA  #206851","ORIG-1","ETHINYL ESTRADIOL; LEVONORGESTREL","AUROBINDO PHARMA LTD","","Approval"
"04/07/2017","BUDESONIDEANDA  #207367","ORIG-1","BUDESONIDE","RISING","","Approval"
"04/07/2017","GENVOYANDA   #207561","SUPPL-10","COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE","GILEAD SCIENCES INC","Labeling","Approval"
"04/07/2017","E-Z-CAT DRYNDA   #208036","SUPPL-5","BARIUM SULFATE","BRACCO","Efficacy","Approval"
"04/07/2017","E-Z-HDNDA   #208036","SUPPL-5","BARIUM SULFATE","BRACCO","Efficacy","Approval"
"04/07/2017","E-Z-PAQUENDA   #208036","SUPPL-5","BARIUM SULFATE","BRACCO","Efficacy","Approval"
"04/07/2017","VARIBAR THIN LIQUIDNDA   #208036","SUPPL-5","BARIUM SULFATE","BRACCO","Efficacy","Approval"
"04/07/2017","DESCOVYNDA   #208215","SUPPL-1","EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE","GILEAD SCIENCES INC","Labeling","Approval"
"04/07/2017","ODEFSEYNDA   #208351","SUPPL-1","EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE","GILEAD SCIENCES INC","Labeling","Approval"
"04/07/2017","VEMLIDYNDA   #208464","SUPPL-1","TENOFOVIR ALAFENAMIDE FUMARATE","GILEAD SCIENCES INC","Labeling","Approval"
"04/10/2017","RETROVIRNDA   #019655","SUPPL-56","ZIDOVUDINE","VIIV HLTHCARE","Labeling","Approval"
"04/10/2017","RETROVIRNDA   #019910","SUPPL-43","ZIDOVUDINE","VIIV HLTHCARE","Labeling","Approval"
"04/10/2017","RETROVIRNDA   #019951","SUPPL-34","ZIDOVUDINE","VIIV HLTHCARE","Labeling","Approval"
"04/10/2017","XALATANNDA   #020597","SUPPL-51","LATANOPROST","UPJOHN","Labeling","Approval"
"04/10/2017","COMBIVIRNDA   #020857","SUPPL-32","LAMIVUDINE; ZIDOVUDINE","VIIV HLTHCARE","Labeling","Approval"
"04/10/2017","MAXITROLNDA   #050023","SUPPL-32","DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE","NOVARTIS","Labeling","Approval"
"04/10/2017","NAFTIFINE HYDROCHLORIDEANDA  #206960","ORIG-1","NAFTIFINE HYDROCHLORIDE","TOLMAR","","Approval"
"04/11/2017","RAPAMUNENDA   #021083","SUPPL-59","SIROLIMUS","PF PRISM CV","Labeling","Approval"
"04/11/2017","RAPAMUNENDA   #021110","SUPPL-76","SIROLIMUS","PF PRISM CV","Labeling","Approval"
"04/11/2017","FENTORANDA   #021947","SUPPL-19","FENTANYL CITRATE","CEPHALON","REMS","Approval"
"04/11/2017","GLIPIZIDEANDA  #074226","SUPPL-14","GLIPIZIDE","MYLAN","Labeling","Approval"
"04/11/2017","GLIPIZIDEANDA  #074226","SUPPL-15","GLIPIZIDE","MYLAN","Labeling","Approval"
"04/11/2017","GLIPIZIDEANDA  #074305","SUPPL-27","GLIPIZIDE","SANDOZ","Labeling","Approval"
"04/11/2017","GLIPIZIDEANDA  #074305","SUPPL-30","GLIPIZIDE","SANDOZ","Labeling","Approval"
"04/11/2017","NICOTINE POLACRILEXANDA  #076569","SUPPL-27","NICOTINE POLACRILEX","P AND L","Labeling","Approval"
"04/11/2017","NICOTINE POLACRILEXANDA  #079038","SUPPL-15","NICOTINE POLACRILEX","P AND L","Labeling","Approval"
"04/11/2017","HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #202991","SUPPL-2","ACETAMINOPHEN; HYDROCODONE BITARTRATE","RHODES PHARMS","Labeling","Approval"
"04/11/2017","TRINTELLIXNDA   #204447","SUPPL-13","VORTIOXETINE HYDROBROMIDE","TAKEDA PHARMS USA","Labeling","Approval"
"04/11/2017","INGREZZANDA   #209241","ORIG-1","VALBENAZINE TOSYLATE","NEUROCRINE","Type 1 - New Molecular Entity","Approval"
"04/12/2017","IMODIUM A-DNDA   #019487","SUPPL-30","LOPERAMIDE HYDROCHLORIDE","J AND J CONSUMER INC","Labeling","Approval"
"04/12/2017","IMODIUM A-DNDA   #019487","SUPPL-32","LOPERAMIDE HYDROCHLORIDE","J AND J CONSUMER INC","Labeling","Approval"
"04/12/2017","IMODIUM A-DNDA   #019860","SUPPL-32","LOPERAMIDE HYDROCHLORIDE","J AND J CONSUMER INC","Labeling","Approval"
"04/12/2017","IMODIUM A-D EZ CHEWSNDA   #020448","SUPPL-11","LOPERAMIDE HYDROCHLORIDE","J AND J CONSUMER INC","Labeling","Approval"
"04/12/2017","IMODIUM MULTI-SYMPTOM RELIEFNDA   #020606","SUPPL-17","LOPERAMIDE HYDROCHLORIDE; SIMETHICONE","J AND J CONSUMER INC","Labeling","Approval"
"04/12/2017","IMODIUM MULTI-SYMPTOM RELIEFNDA   #021140","SUPPL-25","LOPERAMIDE HYDROCHLORIDE; SIMETHICONE","J AND J CONSUMER INC","Labeling","Approval"
"04/12/2017","MAXITROLNDA   #050065","SUPPL-61","DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE","NOVARTIS","Labeling","Approval"
"04/12/2017","NICOTINE POLACRILEXANDA  #074707","SUPPL-54","NICOTINE POLACRILEX","P AND L","Labeling","Approval"
"04/12/2017","NICOTINE POLACRILEXANDA  #079044","SUPPL-15","NICOTINE POLACRILEX","P AND L","Labeling","Approval"
"04/12/2017","FENTANYL CITRATEANDA  #079075","SUPPL-12","FENTANYL CITRATE","WATSON LABS","Labeling","Approval"
"04/12/2017","PROCHLORPERAZINE EDISYLATEANDA  #089523","SUPPL-3","PROCHLORPERAZINE EDISYLATE","HIKMA","Labeling","Approval"
"04/12/2017","LOSARTAN POTASSIUMANDA  #091497","SUPPL-6","LOSARTAN POTASSIUM","PRINSTON INC","Labeling","Approval"
"04/12/2017","LOSARTAN POTASSIUMANDA  #091497","SUPPL-7","LOSARTAN POTASSIUM","PRINSTON INC","Labeling","Approval"
"04/12/2017","ROCURONIUM BROMIDEANDA  #206206","ORIG-1","ROCURONIUM BROMIDE","EUGIA PHARMA","","Approval"
"04/12/2017","BELEODAQNDA   #206256","SUPPL-2","BELINOSTAT","ACROTECH","Labeling","Approval"
"04/12/2017","BUPROPION HYDROCHLORIDEANDA  #207479","ORIG-1","BUPROPION HYDROCHLORIDE","SCIEGEN PHARMS INC","","Approval"
"04/13/2017","VANCOMYCIN HYDROCHLORIDEANDA  #062911","SUPPL-45","VANCOMYCIN HYDROCHLORIDE","HOSPIRA","Labeling","Approval"
"04/13/2017","VANCOMYCIN HYDROCHLORIDEANDA  #062912","SUPPL-58","VANCOMYCIN HYDROCHLORIDE","HOSPIRA","Labeling","Approval"
"04/13/2017","LAMOTRIGINEANDA  #077420","SUPPL-12","LAMOTRIGINE","MYLAN","Labeling","Approval"
"04/13/2017","LAMOTRIGINEANDA  #077420","SUPPL-13","LAMOTRIGINE","MYLAN","Labeling","Approval"
"04/13/2017","LAMOTRIGINEANDA  #077420","SUPPL-15","LAMOTRIGINE","MYLAN","Labeling","Approval"
"04/13/2017","LAMOTRIGINEANDA  #077420","SUPPL-16","LAMOTRIGINE","MYLAN","Labeling","Approval"
"04/13/2017","EPOGEN/PROCRITBLA   #103234","SUPPL-5360","EPOETIN ALFA","AMGEN","","Approval"
"04/13/2017","EPOGEN/PROCRITBLA   #103234","SUPPL-5364","EPOETIN ALFA","AMGEN","","Approval"
"04/13/2017","ARANESPBLA   #103951","SUPPL-5375","DARBEPOETIN ALFA","AMGEN","","Approval"
"04/13/2017","BOSULIFNDA   #203341","SUPPL-7","BOSUTINIB MONOHYDRATE","PF PRISM CV","Efficacy","Approval"
"04/13/2017","BOSULIFNDA   #203341","SUPPL-8","BOSUTINIB MONOHYDRATE","PF PRISM CV","Labeling","Approval"
"04/13/2017","HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #205001","SUPPL-1","ACETAMINOPHEN; HYDROCODONE BITARTRATE","STRIDES PHARMA","Labeling","Approval"
"04/13/2017","PIROXICAMANDA  #208340","ORIG-1","PIROXICAM","UNICHEM","","Approval"
"04/14/2017","COLY-MYCIN MNDA   #050108","SUPPL-33","COLISTIMETHATE SODIUM","PAR STERILE PRODUCTS","Labeling","Approval"
"04/14/2017","NICOTINE POLACRILEXANDA  #076568","SUPPL-31","NICOTINE POLACRILEX","P AND L","Labeling","Approval"
"04/14/2017","FENTANYL CITRATEANDA  #077312","SUPPL-8","FENTANYL CITRATE","PAR PHARM","Labeling","Approval"
"04/14/2017","NICOTINE POLACRILEXANDA  #078697","SUPPL-15","NICOTINE POLACRILEX","P AND L","Labeling","Approval"
"04/14/2017","NICOTINE POLACRILEXANDA  #078699","SUPPL-15","NICOTINE POLACRILEX","P AND L","Labeling","Approval"
"04/14/2017","BUPROPION HYDROCHLORIDEANDA  #078866","SUPPL-11","BUPROPION HYDROCHLORIDE","SUN PHARM","Labeling","Approval"
"04/14/2017","BUPROPION HYDROCHLORIDEANDA  #078866","SUPPL-12","BUPROPION HYDROCHLORIDE","SUN PHARM","Labeling","Approval"
"04/14/2017","PERPHENAZINEANDA  #206691","ORIG-1","PERPHENAZINE","MYLAN","","Approval"
"04/15/2017","LUCENTISBLA   #125156","SUPPL-114","RANIBIZUMAB","GENENTECH","","Approval"
"04/16/2017","SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERNDA   #018090","SUPPL-86","SODIUM CHLORIDE","ICU MEDICAL INC","Labeling","Approval"
"04/17/2017","MYOVIEWNDA   #020372","SUPPL-28","TECHNETIUM TC-99M TETROFOSMIN KIT","GE HEALTHCARE","Labeling","Approval"
"04/17/2017","MYOVIEW 30MLNDA   #020372","SUPPL-28","TECHNETIUM TC-99M TETROFOSMIN KIT","GE HEALTHCARE","Labeling","Approval"
"04/17/2017","NICOTINE POLACRILEXANDA  #074507","SUPPL-59","NICOTINE POLACRILEX","P AND L","Labeling","Approval"
"04/17/2017","NICOTINE POLACRILEXANDA  #076789","SUPPL-23","NICOTINE POLACRILEX","L PERRIGO CO","Labeling","Approval"
"04/17/2017","GLIMEPIRIDEANDA  #076802","SUPPL-18","GLIMEPIRIDE","TEVA","Labeling","Approval"
"04/17/2017","GLIMEPIRIDEANDA  #077274","SUPPL-8","GLIMEPIRIDE","EPIC PHARMA LLC","Labeling","Approval"
"04/17/2017","GLIMEPIRIDEANDA  #077624","SUPPL-6","GLIMEPIRIDE","MYLAN","Labeling","Approval"
"04/17/2017","ZELBORAFNDA   #202429","SUPPL-12","VEMURAFENIB","HOFFMANN LA ROCHE","Labeling","Approval"
"04/17/2017","BUPROPION HYDROCHLORIDEANDA  #205794","SUPPL-1","BUPROPION HYDROCHLORIDE","SCIEGEN PHARMS INC","Labeling","Approval"
"04/17/2017","BUPROPION HYDROCHLORIDEANDA  #206674","SUPPL-1","BUPROPION HYDROCHLORIDE","INVAGEN PHARMS","Labeling","Approval"
"04/17/2017","TECENTRIQBLA   #761034","SUPPL-1","ATEZOLIZUMAB","GENENTECH INC","","Approval"
"04/18/2017","LOPIDNDA   #018422","SUPPL-56","GEMFIBROZIL","PFIZER PHARMS","Labeling","Approval"
"04/18/2017","GLIPIZIDEANDA  #075795","SUPPL-13","GLIPIZIDE","APOTEX","Labeling","Approval"
"04/18/2017","IBUPROFENANDA  #076925","SUPPL-36","IBUPROFEN","PADAGIS US","Labeling","Approval"
"04/18/2017","LEFLUNOMIDEANDA  #077086","SUPPL-17","LEFLUNOMIDE","HERITAGE PHARMS INC","Labeling","Approval"
"04/18/2017","FLUTICASONE PROPIONATEANDA  #077538","SUPPL-15","FLUTICASONE PROPIONATE","APOTEX INC","Labeling","Approval"
"04/18/2017","FLUTICASONE PROPIONATEANDA  #077538","SUPPL-19","FLUTICASONE PROPIONATE","APOTEX INC","Manufacturing (CMC)","Approval"
"04/18/2017","ALENDRONATE SODIUMANDA  #090258","SUPPL-10","ALENDRONATE SODIUM","HANGZHOU BINJIANG","Manufacturing (CMC)","Approval"
"04/18/2017","LAMOTRIGINEANDA  #090401","SUPPL-11","LAMOTRIGINE","AUROBINDO PHARMA","Labeling","Approval"
"04/18/2017","LAMOTRIGINEANDA  #090401","SUPPL-13","LAMOTRIGINE","AUROBINDO PHARMA","Labeling","Approval"
"04/18/2017","LAMOTRIGINEANDA  #090401","SUPPL-14","LAMOTRIGINE","AUROBINDO PHARMA","Labeling","Approval"
"04/18/2017","TEMOZOLOMIDEANDA  #203959","ORIG-1","TEMOZOLOMIDE","WATSON LABS TEVA","","Approval"
"04/18/2017","EPTIFIBATIDEANDA  #204589","ORIG-1","EPTIFIBATIDE","AKORN","","Approval"
"04/18/2017","CETYLEVNDA   #207916","SUPPL-3","ACETYLCYSTEINE","ARBOR PHARMS LLC","Labeling","Approval"
"04/18/2017","MONTELUKAST SODIUMANDA  #209011","ORIG-1","MONTELUKAST SODIUM","ADAPTIS","","Approval"
"04/18/2017","ETOMIDATEANDA  #209058","ORIG-1","ETOMIDATE","GLAND PHARMA LTD","","Approval"
"04/19/2017","XYREMNDA   #021196","SUPPL-26","SODIUM OXYBATE","JAZZ PHARMS","Manufacturing (CMC)","Approval"
"04/19/2017","CEFUROXIME AXETILANDA  #065496","SUPPL-6","CEFUROXIME AXETIL","ALKEM LABS LTD","Manufacturing (CMC)","Approval"
"04/19/2017","DEXLANSOPRAZOLEANDA  #202294","ORIG-1","DEXLANSOPRAZOLE","PAR PHARM INC","","Approval"
"04/19/2017","PROBUPHINENDA   #204442","SUPPL-3","BUPRENORPHINE HYDROCHLORIDE","TITAN PHARMS","REMS","Approval"
"04/19/2017","DABIGATRAN ETEXILATE MESYLATEANDA  #208057","ORIG-1","DABIGATRAN ETEXILATE MESYLATE","TEVA PHARMS USA","","Tentative Approval"
"04/20/2017","NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDEANDA  #075735","SUPPL-11","NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE","LUPIN","Labeling","Approval"
"04/20/2017","NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDEANDA  #075735","SUPPL-12","NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE","LUPIN","Labeling","Approval"
"04/20/2017","TRIAMCINOLONE ACETONIDE IN ABSORBASEANDA  #089595","SUPPL-3","TRIAMCINOLONE ACETONIDE","CMP PHARMA INC","Manufacturing (CMC)","Approval"
"04/20/2017","TRIAMCINOLONE ACETONIDE IN ABSORBASEANDA  #089595","SUPPL-4","TRIAMCINOLONE ACETONIDE","CMP PHARMA INC","Labeling","Approval"
"04/20/2017","BOTOXBLA   #103000","SUPPL-5302","OnabotulinumtoxinA","ALLERGAN","","Approval"
"04/20/2017","BOTOX COSMETICBLA   #103000","SUPPL-5302","OnabotulinumtoxinA","ALLERGAN","","Approval"
"04/20/2017","VIBERZINDA   #206940","SUPPL-2","ELUXADOLINE","ALLERGAN HOLDINGS","Labeling","Approval"
"04/20/2017","FELBAMATEANDA  #207093","ORIG-1","FELBAMATE","TARO","","Approval"
"04/20/2017","CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDENDA   #208083","ORIG-1","CLINDAMYCIN PHOSPHATE","BAXTER HLTHCARE CORP","Type 5 - New Formulation or New Manufacturer","Approval"
"04/20/2017","ROXYBONDNDA   #209777","ORIG-1","OXYCODONE HYDROCHLORIDE","OHEMO LIFE","Type 5 - New Formulation or New Manufacturer","Approval"
"04/21/2017","TRUVADANDA   #021752","SUPPL-53","EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","GILEAD","Labeling","Approval"
"04/21/2017","NUEDEXTANDA   #021879","SUPPL-8","DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE","AVANIR PHARMS","Labeling","Approval"
"04/21/2017","HUMIRABLA   #125057","SUPPL-401","ADALIMUMAB","ABBVIE INC","","Approval"
"04/21/2017","AMABELZANDA  #203339","SUPPL-1","ESTRADIOL; NORETHINDRONE ACETATE","LUPIN LTD","Manufacturing (CMC)","Approval"
"04/21/2017","RENFLEXISBLA   #761054","ORIG-1","INFLIXIMAB-ABDA","SAMSUNG BIOEPIS CO LTD","","Approval"
"04/24/2017","THYROGENBLA   #020898","SUPPL-60","THYROTROPIN ALFA","GENZYME","","Approval"
"04/24/2017","KEPPRANDA   #021035","SUPPL-99","LEVETIRACETAM","UCB INC","Labeling","Approval"
"04/24/2017","KEPPRANDA   #021505","SUPPL-38","LEVETIRACETAM","UCB INC","Labeling","Approval"
"04/24/2017","GLEEVECNDA   #021588","SUPPL-49","IMATINIB MESYLATE","NOVARTIS","Labeling","Approval"
"04/24/2017","KEPPRANDA   #021872","SUPPL-23","LEVETIRACETAM","UCB INC","Labeling","Approval"
"04/24/2017","KEPPRA XRNDA   #022285","SUPPL-25","LEVETIRACETAM","UCB INC","Labeling","Approval"
"04/24/2017","RIFADINNDA   #050420","SUPPL-76","RIFAMPIN","SANOFI AVENTIS US","Labeling","Approval"
"04/24/2017","RIFADINNDA   #050627","SUPPL-17","RIFAMPIN","SANOFI AVENTIS US","Labeling","Approval"
"04/24/2017","RIFATERNDA   #050705","SUPPL-11","ISONIAZID; PYRAZINAMIDE; RIFAMPIN","SANOFI AVENTIS US","Labeling","Approval"
"04/24/2017","FENTANYL CITRATEANDA  #078907","SUPPL-15","FENTANYL CITRATE","SPECGX LLC","Labeling","Approval"
"04/24/2017","OLMESARTAN MEDOXOMILANDA  #091079","ORIG-1","OLMESARTAN MEDOXOMIL","TEVA PHARMS USA","","Approval"
"04/24/2017","PRALUENTBLA   #125559","SUPPL-1","ALIROCUMAB","SANOFI AVENTIS","","Approval"
"04/24/2017","OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEANDA  #200532","ORIG-1","HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL","TEVA PHARMS USA","","Approval"
"04/24/2017","OLMESARTAN MEDOXOMILANDA  #202375","ORIG-1","OLMESARTAN MEDOXOMIL","TORRENT","","Approval"
"04/24/2017","OLMESARTAN MEDOXOMILANDA  #203012","ORIG-1","OLMESARTAN MEDOXOMIL","ALEMBIC PHARMS LTD","","Approval"
"04/24/2017","OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEANDA  #204233","ORIG-1","HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL","ALEMBIC PHARMS LTD","","Approval"
"04/24/2017","BORTEZOMIBANDA  #204405","ORIG-1","BORTEZOMIB","ACCORD HLTHCARE INC","","Tentative Approval"
"04/24/2017","OLMESARTAN MEDOXOMILANDA  #204798","ORIG-1","OLMESARTAN MEDOXOMIL","AUROBINDO PHARMA LTD","","Approval"
"04/24/2017","OLMESARTAN MEDOXOMILANDA  #204814","ORIG-1","OLMESARTAN MEDOXOMIL","MACLEODS PHARMS LTD","","Approval"
"04/24/2017","OLMESARTAN MEDOXOMILANDA  #205192","ORIG-1","OLMESARTAN MEDOXOMIL","ZYDUS PHARMS","","Approval"
"04/24/2017","OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEANDA  #205391","ORIG-1","HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL","AUROBINDO PHARMA LTD","","Approval"
"04/24/2017","OLMESARTAN MEDOXOMILANDA  #205482","ORIG-1","OLMESARTAN MEDOXOMIL","JUBILANT GENERICS","","Approval"
"04/24/2017","OLMESARTAN MEDOXOMILANDA  #206763","ORIG-1","OLMESARTAN MEDOXOMIL","ALKEM LABS LTD","","Approval"
"04/24/2017","OLMESARTAN MEDOXOMILANDA  #207662","ORIG-1","OLMESARTAN MEDOXOMIL","ACCORD HLTHCARE","","Approval"
"04/24/2017","OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEANDA  #207804","ORIG-1","HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL","PRINSTON INC","","Approval"
"04/24/2017","MONTELUKAST SODIUMANDA  #209012","ORIG-1","MONTELUKAST SODIUM","ADAPTIS","","Approval"
"04/25/2017","TIROSINTNDA   #021924","SUPPL-12","LEVOTHYROXINE SODIUM","INSTITUT BIOCHIMIQUE","Labeling","Approval"
"04/25/2017","VICTOZANDA   #022341","SUPPL-28","LIRAGLUTIDE RECOMBINANT","NOVO NORDISK INC","Labeling","Approval"
"04/25/2017","CLOZAPINEANDA  #075417","SUPPL-38","CLOZAPINE","MYLAN","Labeling","Approval"
"04/25/2017","CLOZAPINEANDA  #075417","SUPPL-39","CLOZAPINE","MYLAN","Labeling","Approval"
"04/25/2017","CLOZAPINEANDA  #075417","SUPPL-40","CLOZAPINE","MYLAN","Labeling","Approval"
"04/25/2017","CINACALCET HYDROCHLORIDEANDA  #090539","ORIG-1","CINACALCET HYDROCHLORIDE","TEVA PHARMS","","Tentative Approval"
"04/25/2017","OPDIVOBLA   #125554","SUPPL-31","NIVOLUMAB","BRISTOL MYERS SQUIBB","","Approval"
"04/25/2017","CHOLESTYRAMINE LIGHTANDA  #202902","ORIG-1","CHOLESTYRAMINE","ZYDUS PHARMS","","Approval"
"04/25/2017","LAMOTRIGINEANDA  #203370","SUPPL-2","LAMOTRIGINE","TORRENT","Labeling","Approval"
"04/25/2017","LAMOTRIGINEANDA  #203370","SUPPL-3","LAMOTRIGINE","TORRENT","Labeling","Approval"
"04/25/2017","PREDNISONEANDA  #204867","ORIG-1","PREDNISONE","ACTAVIS LABS FL INC","","Approval"
"04/25/2017","CLOZAPINEANDA  #206433","SUPPL-1","CLOZAPINE","AUROBINDO PHARMA LTD","Labeling","Approval"
"04/25/2017","CLOZAPINEANDA  #206433","SUPPL-2","CLOZAPINE","AUROBINDO PHARMA LTD","Labeling","Approval"
"04/25/2017","XATMEPNDA   #208400","ORIG-1","METHOTREXATE SODIUM","AZURITY","Type 3 - New Dosage Form","Approval"
"04/25/2017","XATMEPNDA   #208400","ORIG-2","METHOTREXATE SODIUM","AZURITY","Efficacy","Approval"
"04/25/2017","BAVENCIOBLA   #761049","SUPPL-1","AVELUMAB","EMD SERONO INC","","Approval"
"04/26/2017","CLARITINNDA   #019658","SUPPL-48","LORATADINE","BAYER HEALTHCARE LLC","Labeling","Approval"
"04/26/2017","CLARITIN HIVES RELIEFNDA   #019658","SUPPL-48","LORATADINE","BAYER HEALTHCARE LLC","Labeling","Approval"
"04/26/2017","OPTIRAY 160NDA   #019710","SUPPL-54","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/26/2017","OPTIRAY 240NDA   #019710","SUPPL-54","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/26/2017","OPTIRAY 300NDA   #019710","SUPPL-54","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/26/2017","OPTIRAY 320NDA   #019710","SUPPL-54","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/26/2017","OPTIRAY 350NDA   #019710","SUPPL-54","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/26/2017","ACCUPRILNDA   #019885","SUPPL-43","QUINAPRIL HYDROCHLORIDE","PFIZER PHARMS","Labeling","Approval"
"04/26/2017","ALTACENDA   #019901","SUPPL-67","RAMIPRIL","KING PHARMS LLC","Labeling","Approval"
"04/26/2017","ACCURETICNDA   #020125","SUPPL-22","HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE","PFIZER PHARMS","Labeling","Approval"
"04/26/2017","OPTIRAY 240NDA   #020923","SUPPL-19","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/26/2017","OPTIRAY 300NDA   #020923","SUPPL-19","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/26/2017","OPTIRAY 320NDA   #020923","SUPPL-19","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/26/2017","OPTIRAY 350NDA   #020923","SUPPL-19","IOVERSOL","LIEBEL-FLARSHEIM","Labeling","Approval"
"04/26/2017","MINOCYCLINE HYDROCHLORIDEANDA  #065485","SUPPL-5","MINOCYCLINE HYDROCHLORIDE","BARR LABS INC","Manufacturing (CMC)","Approval"
"04/26/2017","MINOCYCLINE HYDROCHLORIDEANDA  #065485","SUPPL-8","MINOCYCLINE HYDROCHLORIDE","BARR LABS INC","Manufacturing (CMC)","Approval"
"04/26/2017","HALOPERIDOLANDA  #071173","SUPPL-15","HALOPERIDOL","INNOGENIX","Labeling","Approval"
"04/26/2017","CLOZAPINEANDA  #074949","SUPPL-68","CLOZAPINE","IVAX SUB TEVA PHARMS","Labeling","Approval"
"04/26/2017","CLOZAPINEANDA  #074949","SUPPL-69","CLOZAPINE","IVAX SUB TEVA PHARMS","Labeling","Approval"
"04/26/2017","CLOZAPINEANDA  #074949","SUPPL-72","CLOZAPINE","IVAX SUB TEVA PHARMS","Labeling","Approval"
"04/26/2017","CLOZAPINEANDA  #074949","SUPPL-73","CLOZAPINE","IVAX SUB TEVA PHARMS","Labeling","Approval"
"04/26/2017","CLOZAPINEANDA  #074949","SUPPL-74","CLOZAPINE","IVAX SUB TEVA PHARMS","Labeling","Approval"
"04/26/2017","CLOZAPINEANDA  #076809","SUPPL-31","CLOZAPINE","IVAX SUB TEVA PHARMS","Labeling","Approval"
"04/26/2017","CLOZAPINEANDA  #076809","SUPPL-32","CLOZAPINE","IVAX SUB TEVA PHARMS","Labeling","Approval"
"04/26/2017","CLOZAPINEANDA  #076809","SUPPL-35","CLOZAPINE","IVAX SUB TEVA PHARMS","Labeling","Approval"
"04/26/2017","CLOZAPINEANDA  #076809","SUPPL-36","CLOZAPINE","IVAX SUB TEVA PHARMS","Labeling","Approval"
"04/26/2017","CLOZAPINEANDA  #076809","SUPPL-37","CLOZAPINE","IVAX SUB TEVA PHARMS","Labeling","Approval"
"04/26/2017","EZETIMIBE AND SIMVASTATINANDA  #200909","ORIG-1","EZETIMIBE; SIMVASTATIN","DR REDDYS LABS SA","","Approval"
"04/26/2017","EZETIMIBE AND SIMVASTATINANDA  #201890","ORIG-1","EZETIMIBE; SIMVASTATIN","ANI PHARMS","","Approval"
"04/26/2017","EZETIMIBE AND SIMVASTATINANDA  #202968","ORIG-1","EZETIMIBE; SIMVASTATIN","WATSON LABS INC","","Approval"
"04/26/2017","DEXMEDETOMIDINE HYDROCHLORIDEANDA  #205046","ORIG-1","DEXMEDETOMIDINE HYDROCHLORIDE","HIKMA","","Approval"
"04/26/2017","EZETIMIBE AND ATORVASTATIN CALCIUMANDA  #206084","ORIG-1","ATORVASTATIN CALCIUM; EZETIMIBE","SCOV3","","Approval"
"04/26/2017","MONTELUKAST SODIUMANDA  #206112","ORIG-1","MONTELUKAST SODIUM","L PERRIGO CO","","Approval"
"04/26/2017","SAXENDANDA   #206321","SUPPL-4","LIRAGLUTIDE RECOMBINANT","NOVO","Efficacy","Approval"
"04/26/2017","SAXENDANDA   #206321","SUPPL-6","LIRAGLUTIDE RECOMBINANT","NOVO","Labeling","Approval"
"04/26/2017","TEMOZOLOMIDEANDA  #207658","ORIG-1","TEMOZOLOMIDE","DEVA HOLDING AS","","Approval"
"04/26/2017","NEOSTIGMINE METHYLSULFATEANDA  #208405","ORIG-1","NEOSTIGMINE METHYLSULFATE","PAR STERILE PRODUCTS","","Approval"
"04/26/2017","CARBOPLATINANDA  #208487","ORIG-1","CARBOPLATIN","NOVAST LABS","","Approval"
"04/26/2017","XYROSANDA   #209259","ORIG-1","DOXYCYCLINE","SUN PHARM INDS LTD","Type 3 - New Dosage Form","Tentative Approval"
"04/27/2017","BREVITAL SODIUMNDA   #011559","SUPPL-51","METHOHEXITAL SODIUM","PAR STERILE PRODUCTS","Labeling","Approval"
"04/27/2017","KETALARNDA   #016812","SUPPL-43","KETAMINE HYDROCHLORIDE","PAR STERILE PRODUCTS","Labeling","Approval"
"04/27/2017","FORANENDA   #017624","SUPPL-41","ISOFLURANE","BAXTER HLTHCARE","Labeling","Approval"
"04/27/2017","ATIVANNDA   #018140","SUPPL-41","LORAZEPAM","HIKMA","Labeling","Approval"
"04/27/2017","ATIVANNDA   #018140","SUPPL-42","LORAZEPAM","HIKMA","Labeling","Approval"
"04/27/2017","AMIDATENDA   #018227","SUPPL-32","ETOMIDATE","HOSPIRA","Labeling","Approval"
"04/27/2017","DIPRIVANNDA   #019627","SUPPL-66","PROPOFOL","FRESENIUS KABI USA","Labeling","Approval"
"04/27/2017","SUPRANENDA   #020118","SUPPL-24","DESFLURANE","BAXTER HLTHCARE","Labeling","Approval"
"04/27/2017","SABRILNDA   #020427","SUPPL-16","VIGABATRIN","LUNDBECK PHARMS LLC","Labeling","Approval"
"04/27/2017","ULTANENDA   #020478","SUPPL-30","SEVOFLURANE","ABBVIE","Labeling","Approval"
"04/27/2017","SABRILNDA   #022006","SUPPL-18","VIGABATRIN","LUNDBECK PHARMS LLC","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #075243","SUPPL-26","MIDAZOLAM HYDROCHLORIDE","HIKMA","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #075293","SUPPL-16","MIDAZOLAM HYDROCHLORIDE","HOSPIRA","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #075293","SUPPL-18","MIDAZOLAM HYDROCHLORIDE","HOSPIRA","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #075324","SUPPL-4","MIDAZOLAM HYDROCHLORIDE","HIKMA","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #075481","SUPPL-1","MIDAZOLAM HYDROCHLORIDE","AKORN","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #075494","SUPPL-3","MIDAZOLAM HYDROCHLORIDE","AKORN","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #075637","SUPPL-12","MIDAZOLAM HYDROCHLORIDE","BAXTER HLTHCARE CORP","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #075637","SUPPL-13","MIDAZOLAM HYDROCHLORIDE","BAXTER HLTHCARE CORP","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #075856","SUPPL-11","MIDAZOLAM HYDROCHLORIDE","HOSPIRA","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #075856","SUPPL-12","MIDAZOLAM HYDROCHLORIDE","HOSPIRA","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREEANDA  #075857","SUPPL-12","MIDAZOLAM HYDROCHLORIDE","HOSPIRA","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREEANDA  #075857","SUPPL-14","MIDAZOLAM HYDROCHLORIDE","HOSPIRA","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #075873","SUPPL-10","MIDAZOLAM HYDROCHLORIDE","HIKMA","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #075873","SUPPL-11","MIDAZOLAM HYDROCHLORIDE","HIKMA","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #075958","SUPPL-3","MIDAZOLAM HYDROCHLORIDE","AKORN","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #075958","SUPPL-4","MIDAZOLAM HYDROCHLORIDE","AKORN","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #076020","SUPPL-1","MIDAZOLAM HYDROCHLORIDE","INTL MEDICATION","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #076020","SUPPL-2","MIDAZOLAM HYDROCHLORIDE","INTL MEDICATION","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #076058","SUPPL-7","MIDAZOLAM HYDROCHLORIDE","SUN PHARM INDS LTD","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #076058","SUPPL-8","MIDAZOLAM HYDROCHLORIDE","SUN PHARM INDS LTD","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #076144","SUPPL-1","MIDAZOLAM HYDROCHLORIDE","INTL MEDICATED","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #076144","SUPPL-2","MIDAZOLAM HYDROCHLORIDE","INTL MEDICATED","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #076379","SUPPL-7","MIDAZOLAM HYDROCHLORIDE","PADAGIS US","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #076379","SUPPL-8","MIDAZOLAM HYDROCHLORIDE","PADAGIS US","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #077115","SUPPL-3","MIDAZOLAM HYDROCHLORIDE","PHARM ASSOC","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #077115","SUPPL-4","MIDAZOLAM HYDROCHLORIDE","PHARM ASSOC","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #077115","SUPPL-5","MIDAZOLAM HYDROCHLORIDE","PHARM ASSOC","Labeling","Approval"
"04/27/2017","NEMBUTAL SODIUMANDA  #083246","SUPPL-37","PENTOBARBITAL SODIUM","AKORN","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREEANDA  #090315","SUPPL-7","MIDAZOLAM HYDROCHLORIDE","MYLAN ASI","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREEANDA  #090315","SUPPL-8","MIDAZOLAM HYDROCHLORIDE","MYLAN ASI","Labeling","Approval"
"04/27/2017","MIDOZALAM HYDROCHLORIDEANDA  #090316","SUPPL-7","MIDAZOLAM HYDROCHLORIDE","MYLAN ASI","Labeling","Approval"
"04/27/2017","MIDOZALAM HYDROCHLORIDEANDA  #090316","SUPPL-8","MIDAZOLAM HYDROCHLORIDE","MYLAN ASI","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #090696","SUPPL-7","MIDAZOLAM HYDROCHLORIDE","GLAND PHARMA LTD","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #090696","SUPPL-8","MIDAZOLAM HYDROCHLORIDE","GLAND PHARMA LTD","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #090850","SUPPL-6","MIDAZOLAM HYDROCHLORIDE","GLAND PHARMA LTD","Labeling","Approval"
"04/27/2017","MIDAZOLAM HYDROCHLORIDEANDA  #090850","SUPPL-8","MIDAZOLAM HYDROCHLORIDE","GLAND PHARMA LTD","Labeling","Approval"
"04/27/2017","HERCEPTINBLA   #103792","SUPPL-5337","TRASTUZUMAB","GENENTECH","","Approval"
"04/27/2017","OXYCODONE HYDROCHLORIDEANDA  #202662","SUPPL-4","OXYCODONE HYDROCHLORIDE","EPIC PHARMA LLC","Labeling","Approval"
"04/27/2017","STIVARGANDA   #203085","SUPPL-7","REGORAFENIB","BAYER HLTHCARE","Efficacy","Approval"
"04/27/2017","DESVENLAFAXINE SUCCINATEANDA  #204003","SUPPL-3","DESVENLAFAXINE SUCCINATE","ALEMBIC PHARMS LTD","Labeling","Approval"
"04/27/2017","DESVENLAFAXINE SUCCINATEANDA  #204003","SUPPL-4","DESVENLAFAXINE SUCCINATE","ALEMBIC PHARMS LTD","Labeling","Approval"
"04/27/2017","BUNAVAILNDA   #205637","SUPPL-7","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","BDSI","Efficacy","Approval"
"04/27/2017","BUNAVAILNDA   #205637","SUPPL-13","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","BDSI","Labeling","Approval"
"04/27/2017","PENTOBARBITAL SODIUMANDA  #206404","SUPPL-3","PENTOBARBITAL SODIUM","SAGENT PHARMS INC","Labeling","Approval"
"04/27/2017","OLMESARTAN MEDOXOMILANDA  #206631","ORIG-1","OLMESARTAN MEDOXOMIL","LUPIN LTD","","Approval"
"04/27/2017","HYDROCORTISONEANDA  #207029","ORIG-1","HYDROCORTISONE","STRIDES PHARMA","","Approval"
"04/27/2017","VIGABATRINANDA  #208218","ORIG-1","VIGABATRIN","PAR PHARM INC","","Approval"
"04/27/2017","BRINEURABLA   #761052","ORIG-1","CERLIPONASE ALFA","BIOMARIN PHARM","","Approval"
"04/28/2017","EPI E Z PEN JRNDA   #019430","SUPPL-67","EPINEPHRINE","MYLAN SPECIALITY LP","Labeling","Approval"
"04/28/2017","EPIPENNDA   #019430","SUPPL-67","EPINEPHRINE","MYLAN SPECIALITY LP","Labeling","Approval"
"04/28/2017","EPIPEN E Z PENNDA   #019430","SUPPL-67","EPINEPHRINE","MYLAN SPECIALITY LP","Labeling","Approval"
"04/28/2017","EPIPEN JR.NDA   #019430","SUPPL-67","EPINEPHRINE","MYLAN SPECIALITY LP","Labeling","Approval"
"04/28/2017","FORTEONDA   #021318","SUPPL-51","TERIPARATIDE","LILLY","REMS","Approval"
"04/28/2017","ADVIL ALLERGY AND CONGESTION RELIEFNDA   #022113","SUPPL-1","CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE","GLAXOSMITHKLINE","Efficacy","Approval"
"04/28/2017","ADVIL MULTI-SYMPTOM COLD & FLUNDA   #022113","SUPPL-1","CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE","GLAXOSMITHKLINE","Efficacy","Approval"
"04/28/2017","MEPERIDINE HYDROCHLORIDEANDA  #040110","SUPPL-5","MEPERIDINE HYDROCHLORIDE","HIKMA","Labeling","Approval"
"04/28/2017","OXAZEPAMANDA  #070683","SUPPL-13","OXAZEPAM","SUN PHARM INDUSTRIES","Labeling","Approval"
"04/28/2017","MEPERIDINE HYDROCHLORIDEANDA  #088744","SUPPL-26","MEPERIDINE HYDROCHLORIDE","HIKMA","Labeling","Approval"
"04/28/2017","BUPROPION HYDROCHLORIDEANDA  #090941","SUPPL-9","BUPROPION HYDROCHLORIDE","MYLAN","Labeling","Approval"
"04/28/2017","BUPROPION HYDROCHLORIDEANDA  #090941","SUPPL-10","BUPROPION HYDROCHLORIDE","MYLAN","Labeling","Approval"
"04/28/2017","BUPROPION HYDROCHLORIDEANDA  #091459","SUPPL-9","BUPROPION HYDROCHLORIDE","ANCHEN PHARMS","Labeling","Approval"
"04/28/2017","HUMIRABLA   #125057","SUPPL-402","ADALIMUMAB","ABBVIE INC","","Approval"
"04/28/2017","LORAZEPAMANDA  #200542","ORIG-1","LORAZEPAM","MYLAN ASI","","Approval"
"04/28/2017","XALKORINDA   #202570","SUPPL-19","CRIZOTINIB","PF PRISM CV","Efficacy","Approval"
"04/28/2017","RAVICTINDA   #203284","SUPPL-5","GLYCEROL PHENYLBUTYRATE","HORIZON THERAP","Efficacy","Approval"
"04/28/2017","BRISDELLENDA   #204516","SUPPL-5","PAROXETINE MESYLATE","SEBELA IRELAND LTD","Labeling","Approval"
"04/28/2017","ETHINYL ESTRADIOL; LEVONORGESTRELANDA  #206201","ORIG-1","ETHINYL ESTRADIOL; LEVONORGESTREL","MAYNE PHARMA INC","","Tentative Approval"
"04/28/2017","LO SIMPESSEANDA  #206852","ORIG-1","ETHINYL ESTRADIOL; LEVONORGESTREL","AUROBINDO PHARMA LTD","","Approval"
"04/28/2017","NORETHINDRONE AND ETHINYL ESTRADIOLANDA  #206864","ORIG-1","ETHINYL ESTRADIOL; NORETHINDRONE","NAARI PTE LTD","","Approval"
"04/28/2017","CLOBETASOL PROPIONATEANDA  #207218","ORIG-1","CLOBETASOL PROPIONATE","AKORN","","Approval"
"04/28/2017","AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATEANDA  #207712","ORIG-1","AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE","APOTEX","","Approval"
"04/28/2017","ATOVAQUONEANDA  #207833","ORIG-1","ATOVAQUONE","PADAGIS US","","Approval"
"04/28/2017","RYDAPTNDA   #207997","ORIG-1","MIDOSTAURIN","NOVARTIS","Efficacy","Approval"
"04/28/2017","RYDAPTNDA   #207997","ORIG-2","MIDOSTAURIN","NOVARTIS","Type 1 - New Molecular Entity","Approval"
"04/28/2017","TYMLOSNDA   #208743","ORIG-1","ABALOPARATIDE","RADIUS HEALTH INC","Type 1 - New Molecular Entity and Type 4 - New Combination","Approval"
"04/28/2017","ALUNBRIGNDA   #208772","ORIG-1","BRIGATINIB","TAKEDA PHARMS USA","Type 1 - New Molecular Entity","Approval"